Poultry Healthcare Market Size, Share and Global Trend By Type (Treatment, Diagnosis)and Regional Forecast, 2024-2032

Poultry animals are the domesticated birds that include chicken, turkeys, duck, goose, quails, and others. The poultry industry is one of the growing segment of the livestock animal. According to the National Chicken Council, the per capita chicken consumption in the U.S. grew from 91 pounds to 92.1 pounds during 2016-2017. Poultry farming includes the production of eggs, broilers, and turkeys.

According to the U.S. Poultry & Egg Association, the U.S. registered a growth of an estimated 9.9% of sales of broiler, eggs, and turkeys from US$ 38.7 Bn in 2016 to US$ 42.7 Bn in 2017. To generate revenues from poultry farming, maintaining poultry health is a primarily essential aspect.

Poultry healthcare plays a vital role in generating higher revenues and productivity in poultry farming. Poultry healthcare strategies include eliminating sick birds, timely vaccinations, managing healthcare resources, and poultry management such as cleanliness, feeding & feed supply, housing, and others.

Increasing prevalence of disease outbreaks such as Newcastle disease, avian influenza, and others as well as growing demand for poultry food due to increasing attraction towards poultry farming in emerging and developed countries, are factors driving the global poultry healthcare market growth.

According to the World Organization for Animal Health, an estimated 122 million birds were affected by the Highly Pathogenic Asian Avian Influenza (HPAI) outburst during January 2013 – August 2018 globally. Rising population globally has led to increased consumption of livestock animals. This is one of the significant drivers in the growth of the global poultry healthcare market.

Initiatives taken by governments towards the sustainable development of livestock animals is one of the significant factor driving poultry healthcare market growth. For instance, National Livestock Mission program undertaken by the Indian government and various other programs implemented by animal welfare organizations have been a significant boost for the to the industry’s expansion.

However, presence of counterfeit or falsified products, vaccination failures, and lack of awareness about poultry healthcare in emerging countries are restraining the growth of the global poultry healthcare market.

Key Players Covered

The major companies covered in the global poultry healthcare market report include Ceva, Zoetis, Venkys India, Phibro Animal Health Corporation, Merck & Co., Inc., Boehringer Ingelheim, ROMVAC COMPANY S.A., Hester Biosciences Limited, Indovax, Eli Lilly and Company, and others. 

SEGMENTATION 

As per the current poultry healthcare market trends, vaccines segment among the treatment dominanted the global poultry healthcare market in 2018. This is due to increased prevalence of zoonotic diseases and increased investment in the vaccine development by key market players in order to prevent zoonotic diseases. Medical feed additives are likely to grow at a significant CAGR during the forecast period due to the new drift of administering medicines through feed additives.

Key Insights

• Prevalence of Zoonotic Diseases,2018 by Key Countries/ Region


• New Product Launches, By Key Market Players


• Key Mergers And Acquisitions

Regional Analysis

The global poultry healthcare market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global poultry healthcare market in 2018, followed by Europe. The rise in commercial, as well as family poultry farming, combined with outburst of viral diseases affecting millions of livestock and poultry animals, is one of the major factor driving the market growth in the North America region. Asia Pacific and Middle East & Africa also hold massive potential for growth of the global poultry healthcare market owing to increase in poultry farming.

Poultry Healthcare Industry Developments

• In March 2019, Merck launched next live poultry vaccine in U.S. Innovax ND-ILT provides single injection protection against Newcastle disease, ILT and Marek’s disease.
• In May 2018, Boehringer Ingelheim, investmented in China by expanding the Asian Veterinary Research & Development (R&D) Center to enhance its research and innovation capacity.